This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bonescans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bonescans in calciphylaxis based on a review of the literature.
The new horizons of advanced imaging, especially in oncology, must increasingly consider not only diagnostic efficacy but also sustainability for patients, prize-winning researchers told ECR 2025 delegates. To mitigate these effects, low-energy imaging techniques should be prioritized without compromising diagnostic accuracy.
Prostate-specific membrane antigen (PSMA) PET imaging could improve the length and quality of life for patients with recurrent prostate cancer, according to a study published October 23 in JAMA Network Open. population and was informed by data from real-world settings.
Read more on AuntMinnie.com Related Reading: Can AI bridge the gap between genetics and imaging? Ireland faces high osteoporosis burden Male and female obese patients may respond differently to fasting DEXA shows bone benefits of modest exercise in menopausal women Fracture risk tool validated in men with prostate cancer
F-18 fluroestradiol (FES)-PET/CT appears as effective as standard imaging for staging women with estrogen receptor (ER)-positive locally advanced breast cancer or evaluating suspected recurrence, according to a study published July 26 in JAMA Open Network. Ulaner, MD, PhD, of the University of Southern California, Los Angeles.
Fifty-seven percent of patients with prostate cancer diagnosed with osseous metastases on bonescans had negative findings on PSMA PET imaging, according to findings from an international multicenter comparative study.
SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. In two patients (3%), post-treatment imaging led to miscellaneous changes, they added. A graphical abstract of the study.
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).
I wanted to introduce a new player in the game: gallium-68 GRPR antagonist,” Duan told attendees, during a scientific session on prostate cancer imaging. such as Ga-68 PSMA-11 and F-18 DCFPyl (Pylarify, Lantheus Medical Imaging) and are included in National Comprehensive Cancer Network guidelines, Duan explained.
Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for the preparation of PSMA-PET imaging[1] for prostate cancer. PSMA-PET imaging represents a major advancement in prostate cancer management and in the U.S.
Theranostics is increasingly being used to image and treat prostate cancer and neuroendocrine tumors. Several presenters at the Society for Nuclear Medicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Women's theranostics appears to already be on the horizon.
For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bonescan, according to long-term outcome estimates from a new decision-analytic modeling study.
PET/CT imaging with a new gallium-68-based prostate cancer radiotracer shows promise for detecting recurrent metastatic disease, according to a study published February 20 in the Journal of Nuclear Medicine. Imaging agents with low uptake in at-risk organs and higher tumor uptake are needed, they noted.
While broken bones are common injuries experienced across all ages, older individuals are at higher risk. Bones become more fragile and porous with age, so less force is needed to break their structure. Medical imaging is used to help diagnose these injuries, so doctors can propose appropriate treatment plans.
This AI solution will help Americans become aware of their bone loss before they face negative consequences such as bone fracture. "We HeartLungs AutoBMD AI opportunistically detects osteoporosis in CT scans done for other reasons so the patient receives no extra X-ray radiation or scanning time. References: 1.
An article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bonescan with PSMA PET for initial staging of prostate cancer.
How are imaging experts and others handling NSF? The FDA asked physicians to use alternative methods to image patients with moderate to end-stage renal disease whenever possible. Imaging is generally required for organs other than the kidneys and MR is the first-line imaging exam. Clearly, a major problem is at hand.
mtaschetta-millane Tue, 07/02/2024 - 09:53 July 2, 2024 — A new editorial paper was published in Oncoscience ( Volume 11 ) on May 20, 2024, entitled, “ Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer.” In this new editorial, researchers Richard L.J.
As technological capabilities advance across all medical disciplines, so to do the imaging needs that often come with adequate diagnostic capabilities. Offer Versatility and Clarity to Your Doctors and Patients MRI, or Magnetic Resonance Imaging , could be the most versatile imaging technology available to members of the medical community.
At Clermont Radiology’s Women’s Center, we have created a soothing, spa-like environment staffed with caring experts, to meet all your Women’s Imaging needs. By listening closely to our patients, we have identified 3 “must-haves” that create an ideal women’s imaging experience: Comfort, Convenience, and Confidence.
As I was on the phone with a colleague trying to convince the referrer of why I think a patient has Paget’s disease instead of metastases, I described the cortical thickening of the iliopectineal line and the lack of activity on the bonescan at the site and elsewhere throughout the body. And allow me to tell you why.
Doctors use imaging tests to see inside a patient’s body and diagnose their illnesses and injuries. There are many different types of imaging tests, each with their own method of generating a photo of the inside of the human body. A doctor will often use a diagnostic imaging test to check patients for signs of cancer.
Nuclear scans produce images of the body’s anatomy that cannot be obtained as clearly or fully with other imaging techniques. Nuclear medicine tests use a very small amount of radioactive tracer (radionuclide or radioisotope) which is specific for the organ or tissue to be scanned. We look forward to serving you.
MRI is key to diagnosis, obtain this imaging in all patients who raise clinical suspicion Patients with hemodynamic instability and neurologic compromise warrant empiric antibiotics. Imaging Gadolinium enhanced MRI – modality of choice, highly sensitive and specific ( Mylona 2009 ). J Spinal Disord Tech.
Bonescan shows diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Bonescan showed diffuse uptake in the markedly enlarged right breast secondary to increased blood pool activity and impaired washout. Imaging in inflammatory breast carcinoma.
The scan uses a very low dose of radiation to produce pictures of the inside of the body, particularly around the hips and lower spine, to measure bone mass and strength. A certified radiologic technologist will prepare your images for the radiologist, who will then interpret your results and prepare a report.
Prostate-specific membrane antigen (PSMA)-PET/CT bests conventional imaging when it comes to identifying high-risk, nonmetastatic, hormone-sensitive prostate cancer, researchers have reported.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content